Lithium, a trace element, is being explored at microdoses for its potential neuroprotective and mood-stabilizing effects relevant to healthspan. It is thought to influence pathways like GSK-3β inhibition, autophagy, and neurogenesis, contributing to cellular resilience and brain health. Research suggests potential benefits for cognitive function and reduced risk of neurodegenerative diseases, though more targeted human healthspan data is needed.
Verdict
Promising for neuroprotection; requires careful individual assessment and monitoring.
HEALTHSPAN IMPACT
High Value
RISK LEVEL
Moderate
EVIDENCE GRADE
B
MONTHLY COST
$10 - $30
Protocol
- Commonly taken as lithium orotate in doses ranging from 0.3 mg to 5 mg of elemental lithium daily.
- Higher therapeutic doses of lithium carbonate/citrate for bipolar disorder require strict medical supervision and blood monitoring.
Flags
- Requires physician consultation, especially if on other medications or with kidney conditions.
- Risk of toxicity at higher doses; blood level monitoring is crucial for therapeutic use.
- Potential for interaction with diuretics, ACE inhibitors, and NSAIDs.
- Long-term safety data for chronic microdosing specifically for healthspan is still accumulating.